Skip to content
Triangle logo TriangleGet started
← Full study record

NCT02506959 · MORE INFO

Limitations, agreements, and source contact

Panobinostat, Gemcitabine Hydrochloride, Busulfan, and Melphalan Before Stem Cell Transplant in Treating Patients With Refractory or Relapsed Multiple Myeloma · Source last updated 2025-03-18

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
pi Sponsor Employee
true
point Of Contact
email
ynieto@mdanderosn.org
organization
The University of Texas MD Anderson Cancer Center
phone
713-792-8750
title
Yago Nieto, MD / Stem Cell Transplantation Department
Complete source fields
certain Agreement
pi Sponsor Employee
true
point Of Contact
email
ynieto@mdanderosn.org
organization
The University of Texas MD Anderson Cancer Center
phone
713-792-8750
title
Yago Nieto, MD / Stem Cell Transplantation Department

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice